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Abstract: The aim of this study was to
investigate the effects of splenic artery
ligation on the phagocytic functions and
morphology of the spleen in rabbits in which
secondary hypersplenism was induced by
splenic vein ligation (SVL).
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Thirty New Zealand-type rabbits were
included in this study. The rabbits were
separated into three groups of 10 subjects
each. The first group underwent laparotomy,
and the second and third groups underwent
laparotomy + splenic vein ligation. At the end
of the fourth week, the first and second
groups underwent laparotomy while the third
group underwent laparotomy + splenic artery
ligation. At the end of the eighth week, 1 cc
of blood was taken from all rabbits to
determine hematological parameters. The
rabbits were administered with 0.1 mCi/kg of
Tc-99m sulfur colloid, and retention rates in
the liver and spleen were determined. The
spleens of the rabbits were removed and
examined histopathologically.

Introduction
Although splenectomy is a preferred treatment
modality in patients with primary hypersplenism,
attempts to improve the underlying pathology are given
priority in patients with secondary hypersplenism (1).
Conservative methods have gained still more importance
in the treatment of benign splenic pathologies since the
role and importance of the spleen in the immune system
became better understood (1-5).
Selective arterial embolization and splenic artery
ligation (SAL) are employed in some centers in the
treatment of secondary hypersplenism for the prevention
of the destruction of blood elements, although they are
not very commonly practiced (2,3,6). Despite the fact
that there is currently increasing interest in procedures
that protect the spleen, there are also studies reporting

Median liver/spleen retention rates were
found to be 26.2 count/pixel in the sham
group, 29.1 count/pixel in group II and 55
count/pixel in group III. The retention rate in
the spleen was significantly lower in group III
(p = 0.0001). Leukocyte levels were similar
among the groups while erythrocyte and
thrombocyte levels were significantly lower in
group II than in the other two groups (p =
0.0001). Histopathologically, wide congestion
was observed in group II while extended
fibrosis and necrosis were observed in the
spleens of group III.
Although the application of SAL in secondary
hypersplenism cases reduces the severity of
hypersplenism, it fails to improve the
phagocytic function of the spleen.

Key Words: Hypersplenism, Splenic vein
ligation, Splenic artery ligation, Phagocytosis,
Fibrosis.

that such spleens fail to perform previous functions and
that they lose their phagocytic functions (7-9).
The aim of this study was to investigate
morphological changes in the spleen and determine the
phagocytic capacities of the spleen following the SAL
procedure in rabbits with induced hypersplenism.

Materials and Methods
This study was performed in the Selçuk University
Experimental Medical Research Center in Konya with the
permission of the Selçuk University ethics committee.
Animal control oversight rules in accordance with Turkish
law were followed in this study.
Thirty New Zealand-type rabbits with an average
weight of 3550 ± 370 g were used. The rabbits were
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divided into three groups containing 10 rabbits each. The
animals were left hungry on the morning of the
experiment, and were operated on under ketamine HCl
anesthesia, administered intramuscularly at a dose of 80
mg/kg.
A midline laparotomy was performed after shaving
the abdominal wall and cleaning it with betadine solution.
The sham procedure was performed in group I and the
splenic vein was ligated in groups II and III. The splenic
vein was ligated from the splenic hilum in order to reduce
collateral development to a minimum. Ligation was done
using 3/0 silk, and the abdomen was closed with 2/0
continuous suture. Following the above procedures, the
rabbits were placed in their cages at 22 °C ambient
temperature, and were fed with rabbit diet for a period
of 4 weeks.
Group 1: Laparotomy + sham procedure
Group 2: Laparotomy + splenic vein ligation
Group 3: Laparotomy + splenic vein ligation
At the end of the fourth week, the subjects were reoperated on under ketamine HCl anesthesia applied
intramuscularly at the same dose. After opening the
abdomen, the sham procedure was performed in groups
I and II, and the splenic artery was ligated in group III.
The splenic artery was ligated from the splenic hilum. The
rabbits were returned to their cages, and were fed in the
same manner for a period of 4 weeks.
Group 1: Laparotomy + sham procedure
Group 2: Laparotomy + sham procedure
Group 3: Laparotomy + splenic artery ligation
At the end of the eighth week, 1 cc blood samples
were taken from the subjects and placed into glass tubes
containing Na-EDTA. Afterwards, 0.1 mCi/kg Tc-99m
sulfur colloid was injected intravenously into the rabbits;
15 min after the injection, imaging was performed in an
anterior and posterior position using a low-energy,
general purpose collimator (low energy all
purpose–LEAP). Liver/spleen ratios were calculated by
obtaining the geometrical averages of counts calculated

Parameter
Leukocyte, x103
Erythrocyte, x106
Thrombocyte, x105
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Group I
9.5 ± 1.6
5.2 ± 0.7
4.64 ± 0.4

from the front and rear views of the liver and the spleen
(10). The rabbits were then sacrificed and their spleens
removed for histopathological examination. The extracted
spleens were kept in formalin solution and stained with
hematoxylin-eosin and examined under a light microscope
by a pathologist who was blinded to the composition of
the groups. Hematological parameters were measured on
the blood samples on the same day using an auto-analyzer
(Technicon H-1, USA).
Statistical analyses were performed using MannWhitney U test and Kruskal-Wallis test, and the value of
p < 0.05 was considered statistically significant.

Results
The leukocyte levels of the groups were similar to
each other at the end of the eighth week (p = 0.968);
however, the erythrocyte and thrombocyte levels of the
second group were significantly lower than the levels in
the first and third groups (p = 0.0001 and p = 0.0001
respectively). This decrease was interpreted as an
indication of the successful induction of hypersplenism
with splenic vein ligation (SVL). The similarity of the
parameters in the SAL group to those in the sham group
was interpreted as an improvement in hypersplenism
following SAL (Table 1).
The medians of scintigraphic measurement ratios
(liver/spleen) in the groups were, Group I: 26.2
count/pixel (20.0–36.3), Group II: 29.1 count/pixel
(21.1–32.1) and Group III: 55.0 count/pixel
(47.5–61.4). The average value in Group III was
significantly higher than in the other groups (p =
0.0001), (Table 2). Accordingly, it was concluded that
retention in the spleen decreased and that the liver/spleen
ratio increased (Figure 1).
The histopathological examination revealed that the
spleens of the rabbits in the control group maintained
their normal structures. Examination of the spleens in
group II revealed that veins and sinusoids were filled with
thrombus and that there was a wide congestion (Figure
2). It was noted that trabeculae became thicker in the

Group II

Group III

P

9.4 ± 1.9
3.2 ± 0.5
2.98 ± 0.6

9.6 ± 1.6
4.7 ± 1.0
4.26 ± 0.3

0.968
0.0001
0.0001

Table 1.

Hematological parameters at the end of
eight week.
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Group I

4451/172: 26.2 count/pixel (380/19:20.0 - 435/12:36.3)
1

Table 2.

2

Group II

465 /16 : 29.1 count/pixel (380/18:21.1 - 450/14:32.1)

Group III

4401/82: 55.0 count/pixel (380/8:47.5 - 430/7:61.4)

Median Liver/Spleen ratio of scintigraphic
retention of the groups.

1

Liver scintigraphic retention value, 2Spleen scintigraphic value.

Figure 1a.

Figure 1b.

spleen in group III, and that, in addition, there was an
increase in fibrotic tissue, along with the presence of
partially necrotized regions (Figures 3 and 4).

hypersplenism develops after ligation of the splenic vein
in order to prevent acute splenic sequestration in sickle
cell anemia, and also after splenic vein thrombosis in
normal sized spleens (11,12). In addition, it is possible to
induce hypersplenism successfully by injecting a gelatin
sponge into the peritoneal cavity (13).

Discussion
The most frequent cause of secondary hypersplenism
is portal hypertension developing due to liver cirrhosis.
Stasis of the blood in the spleen as a result of resistance
to venous blood flow of the spleen constitutes the
underlying cause of the developing pathologies (1,6).
Experimental secondary hypersplenism may be
induced in rats by ligating the spleen vein from the splenic
hilum (5). It is reported in the literature that

The first aim in the treatment of secondary
hypersplenism is the correction of the underlying
pathology. However, it is not always possible to improve
primary pathology, and in such cases splenectomy
becomes the only modality available (1). However,
following better understanding of the importance and
role of the spleen in the immune system, interest in
spleen-protecting methods has grown. The most
67
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frequently used methods in this respect are splenic artery
embolization and SAL (2-5,13).
SAL has started to attract attention again recently in
the treatment of portal hypertension and the
hypersplenism connected to it. It is applied in some
centers with some limitation. However, clinical and
experimental studies report controversial results
(2,5,7,14).
In our study, SAL was applied at the end of the fourth
week to rabbits that had developed thrombocytopenia
and erytrocytopenia following SVL application (Group III).
Following the procedure, it was observed that cell counts
reached normal levels at the end of the eighth week,
whereas cell counts in the SVL-applied group remained at
low levels. In contrast with the increase obtained in the
cell counts, one of the most controversial issues is the
development of infarction in the spleen (15). It also
claimed that it is not possible to remedy with the SAL
procedure structural deformations in the spleen subjected
to prolonged congestion (8,9,15).

Figure 1c.
Figure 1.

Scintigraphic appearance of liver and spleen in the three
groups (A: control group, B: group II, C: group III).

Clayer et al. reported that phagocytic cells in the
spleen could not perform normal phagocytosis following
SAL, and that the spleen failed to recover its lost immune
functions (8,9). Some investigators reported that the
sensitivity of the spleen to pneumococci increased in
hypersplenism in rats despite the fact that the spleen had
been protected with SAL (7). Auto-transplantation of
splenic tissue was recommended as an alternative to
splenectomy (16), but it was shown that regenerated
Figure 2.
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Congestion seen in group II. (HE:
x20)
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splenic pulp contained significantly less white pulp and
marginal zone, and the spleen did not have the phagocytic
ability of normal splenic tissue (8,9,17,18). Decreased regrowth of the lymphoid compartments of the spleen was
shown to be responsible for immune dysfunction (8,17).
We noted congestion after splenic vein ligation and
necrosis and fibrosis after splenic artery ligation; in this
way spleen lost its lymphoid tissue.
Partial splenic embolization restored hypersplenism
and blood tests returned to normal; this might be due to

Figure 3.

Fibrosis seen in group III. (HE:
x20)

Figure 4.

Necrosis seen in group III. (HE:
x20)

decreased spleen volume (18,19). Watanabe et al. (17)
showed that infarction developed in splenic parenchyma
after splenic arterial ligation and partial splenic
embolization, and de-vascularization caused a reduction
in spleen volume. It was shown that protective
procedures did not restore immune responses such as the
production of antibodies and phagocytic cell growth (1820). The authors concluded that this result might be due
to infarcted white pulp and lower T-cell production. Our
histopathological findings correlate with their results.
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It was not possible to assess all these claims in our
study. Nevertheless, the development of fibrosis and the
observation of partially infarcted lesions in the spleens of
SAL-applied rabbits are among the findings worth
considering. In addition, in the subjects with previously
induced hypersplenism with SVL and of which
hypersplenism was remedied by SAL, the scintigraphic
examination made using Tc-99m sulfur colloid showed
that radioactive retention in the spleen decreased
significantly. This decrease may be interpreted as a loss of
phagocytic properties due to changes in the spleen, such
as fibrosis and necrosis (17,20).
In conclusion, it is possible to induce successful
hypersplenism using SVL. The hypersplenism formed this

way in our study continued for a period of 8 weeks.
Blood cell counts, which decreased following SVL,
increased again after the SAL procedure, but the spleen
lost its phagocytic functions. Questions on this issue may
be answered by carrying out further investigations using
the same model.
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